GPhA’s Deficit Reduction Proposals Focus On Medicare Low-Income Subsidy, REMS Policies
This article was originally published in The Pink Sheet Daily
Executive Summary
In letters to congressional leaders, generic drug trade group outlines six proposals that it says would save the government billions of dollars and lessen the impact of sequestration cuts.
You may also be interested in...
Brand, Generic Disputes Over Access Move Beyond REMS Restrictions
Generic companies say innovators are using voluntary restricted distribution programs to prevent them from obtaining reference drugs for bioequivalence testing; a July hearing is set in a dispute involving Actelion’s Gaucher disease drug Zavesca, which is not subject to a Risk Evaluation and Mitigation Strategy.
Raising Part D Donut Hole Discounts To 75% Proposed By President
President Obama’s 2014 budget plan contains some new drug reimbursement ideas, including increasing the brand drug discount used in the Medicare Part D donut hole to 75% and slashing the Part B drug rate to ASP+3%.
Raising Part D Donut Hole Discounts To 75% Proposed By President
President Obama’s 2014 budget plan contains some new drug reimbursement ideas, including increasing the brand drug discount used in the Medicare Part D donut hole to 75% and slashing the Part B drug rate to ASP+3%. Many familiar proposals are reprised – a stronger IPAB, mandatory drug rebates for Medicare/Medicaid dual-eligibles, eliminating pay-for-delay generic drug deals and reducing biologic product exclusivity.